HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 26 filers reported holding HISTOGENICS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,000 | -89.0% | 138,192 | -91.6% | 0.00% | – |
| Q4 2018 | $145,000 | -29.3% | 1,642,443 | +336.8% | 0.00% | – |
| Q3 2018 | $205,000 | -89.5% | 376,026 | -49.6% | 0.00% | -100.0% |
| Q2 2018 | $1,957,000 | +96.5% | 746,525 | +106.1% | 0.00% | 0.0% |
| Q1 2018 | $996,000 | +100.4% | 362,196 | +49.4% | 0.00% | 0.0% |
| Q4 2017 | $497,000 | +60.3% | 242,500 | +54.8% | 0.00% | – |
| Q3 2017 | $310,000 | +108.1% | 156,700 | +88.8% | 0.00% | – |
| Q2 2017 | $149,000 | +22.1% | 83,000 | +17.4% | 0.00% | – |
| Q1 2017 | $122,000 | -26.1% | 70,700 | -28.6% | 0.00% | – |
| Q4 2016 | $165,000 | -21.4% | 99,000 | +51.1% | 0.00% | – |
| Q3 2016 | $210,000 | +228.1% | 65,500 | +76.1% | 0.00% | – |
| Q2 2016 | $64,000 | +33.3% | 37,200 | +78.0% | 0.00% | – |
| Q1 2016 | $48,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S Squared Technology, LLC | 1,149,387 | $3,161,000 | 2.71% |
| Abingworth LLP | 888,889 | $2,444,000 | 1.52% |
| Sofinnova Investments, Inc. | 2,077,040 | $5,712,000 | 0.98% |
| Third Security, LLC | 2,690,570 | $7,399,000 | 0.54% |
| Perceptive Advisors | 2,203,277 | $6,059,000 | 0.17% |
| Archon Capital Management LLC | 232,318 | $639,000 | 0.06% |
| Palo Alto Investors LP | 302,922 | $833,000 | 0.04% |
| Rossmore Private Capital | 11,236 | $31,000 | 0.03% |
| BRADLEY FOSTER & SARGENT INC/CT | 72,200 | $199,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 150,000 | $413,000 | 0.00% |